⏱ News is delayed by 15 minutes. Sign in for real-time access.
Sign in
PTHS News
Pelthos Therapeutics Inc.
Pelthos Therapeutics Signs Major Pharmacy Benefit Manager Agreement Expanding Patient Access to ZELSUVMI™ (berdazimer) Topical Gel, 10.3%
globenewswire.com
PTHS
Pelthos Therapeutics to Present at the Piper Sandler 37th Annual Healthcare Conference
globenewswire.com
PTHS
Pelthos Therapeutics Announces Third Quarter Fiscal 2025 Financial Results
globenewswire.com
PTHS
Pelthos Therapeutics Acquires Xepi® (ozenoxacin) Cream, 1% and Announces $18 Million Private Convertible Notes Financing
globenewswire.com
PTHS
Pelthos Therapeutics to Report Third Quarter 2025 Financial Results on November 13, 2025
globenewswire.com
PTHS
Pelthos Therapeutics Launches Moms Against Molluscum Movement to Unite Families Affected by Molluscum Contagiosum
globenewswire.com
PTHS